Market Research Report
Sustained Release Injectables to 2024
|Published by||Greystone Research Associates||Product code||672887|
|Published||Content info||190 Pages
Delivery time: 1-2 business days
|Sustained Release Injectables to 2024|
|Published: August 9, 2018||Content info: 190 Pages||
Improved drug formulation tech-nology and sophisticated injection deices are converging to create opportunities for sustained release dosing. The ability to formulate injectable drugs to increase the duration of efficacy for a given dose and simultaneously reduce the dosing frequency addresses several important health care issues. Less frequent dosing is believed to improve patient safety, reduce the incidence of injection site complications and improve com-pliance with drug protocols. Sustained release formulations mitigate the bolus effect at the time of injection, and thus have a salutary influence on drug side effects.